A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway
Title:
A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway
Author:
Yoon, Sae-Bom Hong, Hyowon Lim, Hee-Jong Choi, Ji Hye Choi, Yoon Pyo Seo, Seong Wook Lee, Hyuk Woo Chae, Chong Hak Park, Woo-Kyu Kim, Hyun Young Jeong, Daeyoung De, Tran Quang Myung, Chang-Seon Cho, Heeyeong
Appeared in:
Acta pharmaceutica sinica B
Paging:
Volume 13 () nr. 3 pages 1093-1109
Year:
2023
Contents:
Publisher:
Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences